Suppression of peripheral blood natural killer cell activity by excess thyroid hormone.
Open Access
- 1 February 1987
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 79 (2) , 404-408
- https://doi.org/10.1172/jci112826
Abstract
Natural killer (NK) cells were assessed in patients with hyperthyroxinemia due to Graves' disease or treatment with thyroxine (T4). Cytolytic activity was measured with 51Cr-labeled K562 tumor cells and NK enumeration was by flow cytometry using NKH-1 monoclonal antibody to identify the relevant surface marker. Activity was uniformly decreased in association with hyperthyroxinemia, regardless of the underlying pathology; however, there was no reduction in the number of NKH-1+ cells. NK activity was enhanced by addition of interleukin 2 (IL-2) in both control and patients' cells although the value in the latter instance failed to reach the basal control level. Production of IL-2 by lymphocytes from hyperthyroxinemic subjects, in response to phytohemagglutinin, was also reduced. Since NK cells are thought to act as a defense against viral infections and some malignancies and may play a role in autoregulation of the immune system, this effect of T4 may have significant biological implications.This publication has 25 references indexed in Scilit:
- Cytolytic T Lymphocytes with Natural Killer Activity in Thyroid Infiltrate of Patients with Hashimoto's Thyroiditis: Analysis at Clonal Level*Journal of Clinical Endocrinology & Metabolism, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- The standardization of NK cell assays for use in studies of biological response modifiersJournal of Immunological Methods, 1984
- Spontaneous Release of Interleukin-2 by Lung T Lymphocytes in Active Pulmonary SarcoidosisNew England Journal of Medicine, 1983
- Peripheral Blood and Intrathyroidal Mononuclear Cell Populations in Patients with Autoimmune Thyroid Disorders Enumerated using Monoclonal Antibodies*Journal of Clinical Endocrinology & Metabolism, 1983
- Elevated serum thyroxine concentration in patients receiving “replacement” doses of levothyroxineJournal of Endocrinological Investigation, 1982
- Peripheral K Lymphocytes in Autoimmune Thyroid Disease: Decrease in Graves' Disease and Increase in Hashimoto's Disease*Journal of Clinical Endocrinology & Metabolism, 1982
- Chemical hyperthyroidism: serum triiodothyronine levels in clinically euthyroid individuals treated with levothyroxineArchives of internal medicine (1960), 1982
- Quantitation of a whole blood assay for human natural killer cell activityJournal of Immunological Methods, 1981
- Clinical Significance of Assay of Thyroid-Stimulating Antibody in Graves' DiseaseAnnals of Internal Medicine, 1980